Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for +publisher:"Nelson Mandela Metropolitan University" +contributor:("Burton, S"). Showing records 1 – 2 of 2 total matches.

Search Limiters

Last 2 Years | English Only

No search limiters apply to these results.

▼ Search Limiters


Nelson Mandela Metropolitan University

1. Keele, Mothobi Godfrey. Availability of pharmacoeconomic data and its use in the development of drug formularies in South Africa.

Degree: MPharm, Faculty of Health Sciences, 2008, Nelson Mandela Metropolitan University

In an attempt to manage scarce health care resources and keep drug expenditure low, health care administrators worldwide have to make careful considerations regarding the choice of drugs to be provided to patients within their systems. One of the key strategies that is being employed to achieve this goal is the use of formularies. A major challenge in the formulary development process is to use pharmacoeconomics and outcomes research effectively to arrive at formularies that simultaneously provide patients with effective pharmacotherapy whilst maintaining financial stability. The extent to which this can be successfully achieved depends to a large extent on the availability of appropriate pharmacoeconomic data. The primary objectives of this study were to describe the availability and quality of literature pertaining to South African based pharmacoeconomic research, and to establish the manner in and extent to which pharmacoeconomic data is used in drug formulary decision-making processes, in both the private and public health care sectors in South Africa. A structured bibliographic search for South African pharmacoeconomic studies was conducted and a qualitative assessment of the identified studies which met the predetermined inclusion criteria was completed, using a pre-validated quality evaluation tool. In order to determine the use of pharmacoeconomic data in the formulary decisionmaking processes, by various stake holders in both the public and private of health care sectors in South Africa, a cross-sectional, descriptive study using a self-administered questionnaire was conducted. The results suggest that there is a limited availability of pharmacoeconomic research data in South Africa. Only 16 full pharmacoeconomic studies could be identified as having been published between 01 January 1995 and 30 June 2007. The quality of 3 of these studies was considered to be ‘dubious’, one study was found to be of high standard whilst the other 12 (74.95%) were of acceptable quality and thus could be considered as suitable to be used in formulary decision-making. The results of the national survey indicated that pharmacoeconomics is considered to be of importance and is used in formulary decision-making processes in both the public and private sectors. The primary source of pharmacoeconomic data used in formulary decisions appears to be international peer-reviewed publications. Of concern however, is the finding that this data, mostly from studies conducted outside of South Africa, is applied directly without sensitivity analysis or modelling. The results of the literature search and the subsequent quality appraisal suggest that pharmacoeconomic research and the use of pharmacoeconomic data in formulary decisions is at its infancy in South Africa. Thus efforts are needed to develop and grow the discipline of pharmacoeconomics in South Africa Advisors/Committee Members: Burton, S.

Subjects/Keywords: Drugs  – Cost effectiveness; Pharmacy  – Economic aspects

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Keele, M. G. (2008). Availability of pharmacoeconomic data and its use in the development of drug formularies in South Africa. (Masters Thesis). Nelson Mandela Metropolitan University. Retrieved from http://hdl.handle.net/10948/685

Chicago Manual of Style (16th Edition):

Keele, Mothobi Godfrey. “Availability of pharmacoeconomic data and its use in the development of drug formularies in South Africa.” 2008. Masters Thesis, Nelson Mandela Metropolitan University. Accessed June 17, 2019. http://hdl.handle.net/10948/685.

MLA Handbook (7th Edition):

Keele, Mothobi Godfrey. “Availability of pharmacoeconomic data and its use in the development of drug formularies in South Africa.” 2008. Web. 17 Jun 2019.

Vancouver:

Keele MG. Availability of pharmacoeconomic data and its use in the development of drug formularies in South Africa. [Internet] [Masters thesis]. Nelson Mandela Metropolitan University; 2008. [cited 2019 Jun 17]. Available from: http://hdl.handle.net/10948/685.

Council of Science Editors:

Keele MG. Availability of pharmacoeconomic data and its use in the development of drug formularies in South Africa. [Masters Thesis]. Nelson Mandela Metropolitan University; 2008. Available from: http://hdl.handle.net/10948/685


Nelson Mandela Metropolitan University

2. Venter, Ignatius Johannes Erhardt. The role of the community pharmacist in cardiovascular disease management.

Degree: MPharm, Faculty of Health Sciences, 2007, Nelson Mandela Metropolitan University

Cardiovascular disease contributes to mortality and morbidity statistics worldwide and in South Africa. The current focus in health care revolves around activities aimed at preventing the development of cardiovascular disease, rather than the treatment of disease. The identification of risk factors that can predispose a patient to the development of cardiovascular disease is an essential component of any cardiovascular disease management programme. It is necessary that in the management of these risk factors, they are not considered to be isolated, but inter-related. Through the provision of point-of-care cardiovascular risk screening and monitoring services as well as disease-related counselling, the community pharmacist, as a readily accessible source of healthcare, can play an essential role in the cardiovascular disease management process. The aim of this study was to describe the nature of the services provided by community pharmacists with respect to cardiovascular risk and disease management in the Nelson Mandela Metropole. The research design was a non-experimental, descriptive study using a crosssectional survey method. Data was obtained through the utilisation of a questionnaire. The questionnaire consisted of three sections and was administered to community pharmacies in the Nelson Mandela Metropole, that provided cardiovascular point-of-care screening services. The community pharmacists correctly identified cardiovascular risk factors such as obesity (76.6 percent; 36, n=47) and smoking (27.7 percent; 13, n=47). Other cardiovascular risk factors such as abdominal obesity (4.2 percent; 2, n=47), gender (2.1 percent; 1, n=47) and family history (4.2 percent; 2, n=47) were largely ignored by the pharmacists. Point-of-care testing services were readily available in the pharmacies, with all of the pharmacies providing blood glucose and blood pressure measurements. Blood cholesterol measurements were only provided in 87.8 percent (36, n=41) of the pharmacies. The services were generally provided in a clinic facility, with 90.2 percent (37, n=41) of the pharmacies having a clinic facility available. Pharmacists were involved in the provision of point-of-care services, with 85.4 percent (35, n=41) of the pharmacies indicating that the pharmacists participated. Pharmacists readily provided counselling prior (70.7 percent; 29, n=41) to and after (80.5 percent; 33, n=41) the conduction of the screening services on areas such as lifestyle modification and treatment options. Only 15 percent (7, n=47) of the pharmacists indicated that they were aware of Cardiovascular Risk Calculator Tools and none of the pharmacists indicated that they had utilised such a tool. Pharmacists recommended frequent monitoring (60.5 percent; 26, n=43) and lifestyle modification (67.4 percent; 29, n=43) to patients, if the result of their screening service was within normal limits. However, the majority of the pharmacists indicated that they would refer patients, if the results obtained were out of the normal range. Conclusions based on the… Advisors/Committee Members: McCartney, J, Burton, S.

Subjects/Keywords: Pharmacist and patient  – South Africa  – Port Elizabeth; Phamaceutical services  – Patients; Cardiovascular system  – Diseases

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Venter, I. J. E. (2007). The role of the community pharmacist in cardiovascular disease management. (Masters Thesis). Nelson Mandela Metropolitan University. Retrieved from http://hdl.handle.net/10948/652

Chicago Manual of Style (16th Edition):

Venter, Ignatius Johannes Erhardt. “The role of the community pharmacist in cardiovascular disease management.” 2007. Masters Thesis, Nelson Mandela Metropolitan University. Accessed June 17, 2019. http://hdl.handle.net/10948/652.

MLA Handbook (7th Edition):

Venter, Ignatius Johannes Erhardt. “The role of the community pharmacist in cardiovascular disease management.” 2007. Web. 17 Jun 2019.

Vancouver:

Venter IJE. The role of the community pharmacist in cardiovascular disease management. [Internet] [Masters thesis]. Nelson Mandela Metropolitan University; 2007. [cited 2019 Jun 17]. Available from: http://hdl.handle.net/10948/652.

Council of Science Editors:

Venter IJE. The role of the community pharmacist in cardiovascular disease management. [Masters Thesis]. Nelson Mandela Metropolitan University; 2007. Available from: http://hdl.handle.net/10948/652

.